Compounded Drugs and FDA-Declared Drug Shortages Due to the increased popularity of GLP-1 drugs for treatment of diabetes and for weight management, many of the FDA-approved drugs have experienced drug shortages over the past few years
That pattern typically indicates that the quality of experience depends heavily on individual factors like which compounding pharmacy fills your order, whether your medication arrives promptly, and whether you happen to need customer support during a responsive period
Additional trial results for orforglipron are expected later this year
In recent years, they have gained widespread attention because they can also help patients lose weight by reducing appetite and slowing digestion
Significant price reductions have reshaped the cost picture
Clinical Trials & Approval The clinical development phase begins with Investigational New Drug (IND) submissions and proceeds through Phase I trials for safety and pharmacokinetics, Phase II for dose optimization and early efficacy, and Phase III for large-scale confirmation of therapeutic benefits
